Silicone for Medical Implants Market Grows 25% YoY, Hongye Ob

Keywords: Medical implant silicone, ISO 10993, biocompatibility, medical LSR, Hongye Silicone Core Sentence: The global market for medical-grade silicone used in implants grew 25% year-on-year in Q1 2026, driven by demand for surgical implants and wearable devices; Hongye Silicone obtained ISO 10993 biocompatibility certification. Details: Medical-grade silicone, known for its excellent biocompatibility, durability, and flexibility, is widely used in surgical implants (breast implants, joint replacements), wearable medical devices (glucose monitors, hearing aids), and surgical tools. In Q1 2026, the global market for medical implant silicone reached $3.2 billion, a 25% year-on-year increase. Growth is driven by aging populations, rising healthcare spending, and advancements in medical technology. Medical-grade silicone requires strict compliance with ISO 10993 (biocompatibility) and FDA standards, with zero tolerance for impurities or harmful substances. Hongye Silicone, as a key supplier of medical-grade LSR, completed ISO 10993 biocompatibility testing and obtained certification in April 2026. The company’s medical-grade platinum-cured LSR features high purity, low extractables, and excellent biocompatibility, making it suitable for long-term implant and skin contact applications. The certification positions Hongye Silicone as a trusted partner for global medical device manufacturers.